Skip to search formSkip to main contentSkip to account menu

MK 0679

Known as: MK-0679, MK-679 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

verlukast

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Dose-dependent kinetics of the enantiomers of MK-571, an LTD4-receptor antagonist
SummaryThe disposition of the enantiomers of MK-571 (MK-0679 and L-668,018) following single i. v. doses of MK-571 (L-660,711… 
Review
2004
Review
2004
Leukotriene antagonists and inhibitors as modulators of IgE-mediated reactions
ConclusionsThe biological activities of the leukotrienes and the fact that they are produced in elevated amounts in asthmatic… 
Highly Cited
1996
Highly Cited
1996
Induction of hyperresponsiveness in human airway tiss by neutrophils — mechanism of action
Background The two main features of asthtna are bronchial hyperresponsiveness and inflammation. The inflammatory response in… 
1994
1994
The bioavailability and nonlinear pharmacokinetics of MK‐679 in humans
MK‐679 (R(−)‐3‐((3‐(2‐(7‐chloro‐2‐quinolinyl)ethenyl)phenyl)(3‐(dimethylamino)‐3‐oxopropyl)thio)methyl)thio(propanoic acid) is a… 
1992
1992
Bronchodilator properties of an inhaled leukotriene D4 antagonist (verlukast--MK-0679) in asthmatic patients.
1992
1992
Enzymes and practical asymmetric synthesis
Abstract 
1991
1991
Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571.
Verlukast (MK-679) (3-[(3-(2-(7-chloro-2-quinolinyl)-(E)-ethenyl)phenyl)[3-(dimethylamino)- 3- oxopropyl)thio)methyl)-thio… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)